Coltene Holding AGXSWX:CLTN -1.76%69 EV-to-FCF is 42.35 as of Jul. 03, 2026, which is 70% above its 10-year median of 24.94. GuruFocus rates XSWX:CLTN with a GF Score™ of 69/100 and a GF Value™ of CHF55.14 (Fairly Valued). The stock has 3 warning signs investors should review. Among 417 Medical Devices & Instruments companies, Coltene Holding AG ranks worse than 72.18% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Coltene Holding AG's Enterprise Value is CHF325.7 Mil.
Coltene Holding AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was CHF7.7 Mil. Therefore, Coltene Holding AG's EV-to-FCF for today is 42.35.
The historical rank and industry rank for Coltene Holding AG's EV-to-FCF or its related term are showing as below:
XSWX:CLTN'
s EV-to-FCF Range Over the Past 10 Years
Min: 12.28 Med: 24.94 Max: 57.01
Current: 43.36
During the past 13 years, the highest EV-to-FCF of Coltene Holding AG was 57.01. The lowest was 12.28. And the median was 24.94.
XSWX:CLTN's EV-to-FCF is ranked worse than 72.18% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 22.52
vs XSWX:CLTN: 43.36
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Coltene Holding AG (XSWX:CLTN) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Coltene Holding AG's PE Ratio (TTM) for today is calculated as:
Coltene Holding AG's share price for today is CHF50.10.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Coltene Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF2.500.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Coltene Holding AG EV-to-FCF Related Terms
Coltene Holding AG EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Coltene Holding AG's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:CLTN vs ISRG, BDX, MDLN: EV-to-FCF Comparison
For the Medical Instruments & Supplies subindustry, Coltene Holding AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coltene Holding AG EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Coltene Holding AG's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Coltene Holding AG's EV-to-FCF falls into.
Coltene Holding AG's current Enterprise Value is CHF325.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Coltene Holding AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was CHF7.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coltene Holding AG (XSWX:CLTN) has a EV-to-FCF of 42.35 as of Jul. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Coltene Holding AG and its competitors. This is 70% above median its historical median of 24.94. Over the past decade, Coltene Holding AG's EV-to-FCF has ranged from 12.28 to 57.01. According to the industry distribution chart, Coltene Holding AG ranks #301 out of 417 companies in the Medical Devices & Instruments industry, placing it in the top 72.2%.
Is Coltene Holding AG's EV-to-FCF too high?
Coltene Holding AG's current EV-to-FCF of 42.35 is 70% above median its 10-year median of 24.94. Over the past 10 years, this metric has ranged from a low of 12.28 to a high of 57.01. The Medical Devices & Instruments industry median EV-to-FCF is 22.52. Coltene Holding AG's value of 42.35 is 88.1% above this industry median. Based on the distribution chart, Coltene Holding AG ranks #301 out of 417 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Coltene Holding AG has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Coltene Holding AG's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Coltene Holding AG ranks #301 out of 417 companies for EV-to-FCF. This places Coltene Holding AG in the lower half of its industry. The industry median EV-to-FCF is 22.52. Coltene Holding AG's value of 42.35 is 88.1% above this benchmark. Historically, Coltene Holding AG's own EV-to-FCF has ranged from 12.28 to 57.01 over the past decade. While the company's 10-year median is 24.94 vs. the industry median of 22.52, Coltene Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.52, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Coltene Holding AG's current EV-to-FCF of 42.35 is 88.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Coltene Holding AG and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coltene Holding AG's current EV-to-FCF is 42.35, which is 70% above median its own 10-year median of 24.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coltene Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Coltene Holding AG (XSWX:CLTN) is currently considered Fairly Valued. The stock's GF Value™ is CHF55.14, compared to a current price of CHF50.10 — trading 9.1% below its estimated fair value. The current EV-to-FCF is 42.35, which is 70% above median its 10-year median of 24.94 and 88.1% above the Medical Devices & Instruments industry median of 22.52. Coltene Holding AG's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Coltene Holding AG (XSWX:CLTN), the current EV-to-FCF is 42.35 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coltene Holding AG (XSWX:CLTN) Overvalued in 2026?
Based on GuruFocus' analysis, Coltene Holding AG stock appears to be undervalued.
The current stock price of CHF50.10 is trading 9.1% below its estimated GF Value™ of CHF55.14.
GuruFocus considers Coltene Holding AG to be Fairly Valued.
Key valuation signals for XSWX:CLTN:
EV-to-FCF: 42.35 (70% above median its 10-year median of 24.94)
GF Value™: CHF55.14 vs. price of CHF50.10 (9.1% below fair value)
Industry Position: 88.1% above the Medical Devices & Instruments median (#301 of 417)
No single metric tells the full story. See the XSWX:CLTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coltene Holding AG is a manufacturer and distributor of consumables and small devices for dental practices, dental service organisations (DSOs), dental clinics and laboratories, as well as for non-dental niches (e.g., clinics for ophthalmology or podiatry). The Group develops, manufactures, and sells mainly via distribution channels a broad and comprehensive range of disposables, tools, and equipment for dentists and dental laboratories. Geographically, it operates in EMEA, North America, Latin America, and Asia/Oceania, with maximum from North America.
69GF Score
Get the complete analysis for XSWX:CLTN
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:CLTN has been successfully added to your 
